BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 17644333)

  • 1. Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.
    Musonda CC; Little S; Yardley V; Chibale K
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4733-6. PubMed ID: 17644333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol.
    Musonda CC; Gut J; Rosenthal PJ; Yardley V; Carvalho de Souza RC; Chibale K
    Bioorg Med Chem; 2006 Aug; 14(16):5605-15. PubMed ID: 16690319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents.
    Kumar A; Srivastava K; Raja Kumar S; Puri SK; Chauhan PM
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6530-3. PubMed ID: 18951791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
    Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
    Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
    J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.
    Opsenica I; Opsenica D; Lanteri CA; Anova L; Milhous WK; Smith KS; Solaja BA
    J Med Chem; 2008 Oct; 51(19):6216-9. PubMed ID: 18774792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity.
    Sparatore A; Basilico N; Parapini S; Romeo S; Novelli F; Sparatore F; Taramelli D
    Bioorg Med Chem; 2005 Sep; 13(18):5338-45. PubMed ID: 16054368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues.
    Biot C; Pradines B; Sergeant MH; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6434-8. PubMed ID: 17949976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
    Solomon VR; Puri SK; Srivastava K; Katti SB
    Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of phenylequine for antimalarial activity in vitro and in vivo.
    Blackie MA; Yardley V; Chibale K
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1078-80. PubMed ID: 20034790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the role of the covalent linkage of ferrocene into a chloroquine template.
    Biot C; Daher W; Ndiaye CM; Melnyk P; Pradines B; Chavain N; Pellet A; Fraisse L; Pelinski L; Jarry C; Brocard J; Khalife J; Forfar-Bares I; Dive D
    J Med Chem; 2006 Jul; 49(15):4707-14. PubMed ID: 16854077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplasmodial activities of 4-aminoquinoline-statine compounds.
    Vaiana N; Marzahn M; Parapini S; Liu P; Dell'Agli M; Pancotti A; Sangiovanni E; Basilico N; Bosisio E; Dunn BM; Taramelli D; Romeo S
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5915-8. PubMed ID: 22884991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squaric acid/4-aminoquinoline conjugates: novel potent antiplasmodial agents.
    Ribeiro CJ; Kumar SP; Gut J; Gonçalves LM; Rosenthal PJ; Moreira R; Santos MM
    Eur J Med Chem; 2013 Nov; 69():365-72. PubMed ID: 24077527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of the chemical structure of terpenes in antiplasmodial and antifungal drug research.
    Olagnier D; Costes P; Berry A; Linas MD; Urrutigoity M; Dechy-Cabaret O; Benoit-Vical F
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6075-8. PubMed ID: 17904365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.
    Sinha M; Dola VR; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
    Bioorg Med Chem; 2014 Jul; 22(14):3573-86. PubMed ID: 24906512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives.
    Chiyanzu I; Clarkson C; Smith PJ; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem; 2005 May; 13(9):3249-61. PubMed ID: 15809160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling.
    Gemma S; Kukreja G; Campiani G; Butini S; Bernetti M; Joshi BP; Savini L; Basilico N; Taramelli D; Yardley V; Bertamino A; Novellino E; Persico M; Catalanotti B; Fattorusso C
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3535-9. PubMed ID: 17493808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
    Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antimalarial activity of derivatives of 1,10-phenanthroline framework.
    Yapi AD; Valentin A; Chezal JM; Chavignon O; Chaillot B; Gerhardt R; Teulade JC; Blache Y
    Arch Pharm (Weinheim); 2006 Apr; 339(4):201-6. PubMed ID: 16586427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.